Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Gynecologic Cancers
•
Endometrial Cancer
•
NCI-CCC Tumor Board Question
•
NCI-CCC Gynecologic Tumor Board Question
•
University of Pennsylvania
What adjuvant therapy do you recommend for comprehensively staged, stage II, FIGO grade 3 deeply invasive endometrial cancer?
Answer from: at Community Practice
I would strongly consider external beam therapy and adjuvant chemotherapy.
Sign in or Register to read more
9480
Related Questions
How do you classify extensive LVSI in endometrial cancer?
When do you consider adjuvant chemotherapy and/or RT for stage I-III high-grade uterine sarcomas s/p resection?
Would you consider offering immunotherapy +/- olaparib to a patient with early-stage endometrial carcinoma for whom you are recommending adjuvant chemotherapy based on improved outcomes seen in RUBY/DUO-E/NRG-GY018?
How would you manage a POLE mutated, p53 abnormal IA myoinvasive carcinosarcoma of the endometrium with no LVSI?
If you recommend chemotherapy for early-stage uterine serous carcinoma, do you prefer 3 or 6 cycles?
For a diabetic patient with presumed stage I Grade 1 endometrial cancer, what Hemoglobin A1C level would prompt you to recommend medical management instead of surgery?
Would you consider the addition of trastuzumab to carboplatin/paclitaxel for an advanced uterine carcinosarcoma that stains HER2 IHC 3+ in the carcinomatous components but IHC 0 in the sarcomatous regions?
How do you manage a distal vaginal recurrence of endometrial adenocarcinoma in a patient who had adjuvant external beam and cylinder brachytherapy boost to the top 4 cm of the vaginal cuff?
How would you approach the management of a women who was incidentally found to have a deeply invasive low-grade endometrial carcinoma after she underwent a supracervical hysterectomy with placement of mesh for uterine prolapse?
What is your preferred method of endometrial sampling during medical management of endometrial cancer?